Aug 06, 2026
IGF-1 LR3 and AOD-9604 for Tendon Repair: FDA Panel Lessons
IGF-1 LR3 and AOD-9604 are under scrutiny for tendon repair after an FDA panel endorsement. This article examines mechanisms, animal...
Read articleFIELD NOTES
Reading material for serious researchers.
Research notes, product guides, and insights from the Lakeshore Peptides team.
Aug 04, 2026
IGF-1 LR3 and Thymosin Alpha-1 for Post-Injury Immune Support
Examining the research behind IGF-1 LR3 and Thymosin Alpha-1 for post-injury immune support, including lessons from the VA GLP-1 alcohol...
Read articleJul 30, 2026
IGF-1 LR3 vs. TB-500 for Ligament Recovery: FDA Panel Vote
IGF-1 LR3 and TB-500 show promise for ligament recovery in animal studies, but the FDA panel vote limits compounding access....
Read articleJul 28, 2026
IGF-1 LR3 and KPV for Muscle Repair: FDA Panel Vote Impact
IGF-1 LR3 and KPV are studied for muscle repair, but the FDA panel vote on compounded anti-inflammatory stacks signals tighter...
Read articleJul 22, 2026
BPC-157 for Tendon Healing: 2026 Recovery Times Research
BPC-157 shows promise for tendon healing in animal studies, with faster recovery times and improved collagen organization. Human data remain...
Read article